Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

NCT03411967 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Apatinib
DRUG: Docetaxel

Sponsor

Zigong No.1 Peoples Hospital

Collaborators

[object Object]